Continuous temperature monitoring for the detection of fever in haemato‐oncology patients: a pilot study of two wearable devices ( <scp>THERMAL</scp> )
This pilot study explored the acceptability and feasibility of two continuous temperature monitoring devices, CORE® and TempTraq®, in 15 inpatients at risk of neutropenic fever (NF) or cytokine release syndrome (CRS) after chemotherapy, stem cell transplant or chimeric antigen receptor (CAR) T cells. Each device was worn for a median of ≥95% of the study, correlated with tympanic temperature and exhibited potential for early detection of NF or CRS (ClinicalTrials.gov NCT05203809).
Authors
- Maria Larsen (ORCID: https://orcid.org/0009-0008-9359-6611)
- Robert Fyfe
- Danielle Blud
- Robert Weinkove
Institutions
- Malaghan Institute of Medical Research (NZ)
- Capital and Coast District Health Board (NZ)
- University of Otago (NZ)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1111/imj.70199
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Otago
- Thompson Family Foundation